Free Access
Issue
Med Sci (Paris)
Volume 29, Number 5, Mai 2013
Page(s) 539 - 544
Section Forum
DOI https://doi.org/10.1051/medsci/2013295019
Published online 28 May 2013
  1. Rochefort H, Jouannet P. Perturbateurs endocriniens et cancers hormono-dépendants/Risques potentiels et Mécanismes. Bull Acad Natl Med 2011 ; 195 : 51–65. [Google Scholar]
  2. Cravedi JP, Zalko D, Savouret JF, et al. Le concept de perturbation endocrinienne et la santé humaine. Med Sci (Paris) 2007 ; 23: 198–204. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 2009 ; 30 : 293–342. [CrossRef] [PubMed] [Google Scholar]
  4. Zoeller RT, Brown TR, Doan LL, et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology 2012 ;153 : 4097–4110. [CrossRef] [PubMed] [Google Scholar]
  5. Belot A, Grosclaude P, Bossard N, et al. Cancer incidence and mortality in France over the period 1980–2005. Rev Epidemiol Sante Publique 2008 ; 56 : 159–175. [CrossRef] [PubMed] [Google Scholar]
  6. Multigner L, Ndong JR, Giusti A, et al. Chlordecone exposure and risk of prostate cancer. J Clin Oncol 2010 ; 28 : 3457–3462. [CrossRef] [PubMed] [Google Scholar]
  7. Rochefort H. Cancérogenèse hormonale chez la femme: des mécanismes à la prévention. C R Biol (Acad sciences) 2008 ; 331 : 104–113. [CrossRef] [Google Scholar]
  8. Brody JG, Moysich KB, Humblet O, et al. Environmental pollutants, breast cancer: epidemiologic studies. Cancer 2007 ; 109 : 12 suppl 2667–2711. [CrossRef] [PubMed] [Google Scholar]
  9. Hoover RN, Hyer M, Pfeiffer RM, et al. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 2011 ; 365 : 1304–1314. [CrossRef] [PubMed] [Google Scholar]
  10. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 1993 ; 132 : 2279–2286. [CrossRef] [PubMed] [Google Scholar]
  11. Vom Saal FS, Akingbemi BT, Belcher SM, et al. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 2007 ; 24 : 131–138. [CrossRef] [PubMed] [Google Scholar]
  12. Keri RA, Ho SM, Hunt PA, et al. An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod Toxicol 2007 ; 24 : 240–252. [CrossRef] [PubMed] [Google Scholar]
  13. Wadia PR, Vandenberg LN, Schaeberle CM, et al. Perinatal bisphenol A exposure increases estrogen sensitivity of the mammary gland in diverse mouse strains. Environ Health Perspect 2007 ; 115 : 592–598. [CrossRef] [PubMed] [Google Scholar]
  14. Vandenberg LN, Colborn T, Hayes TB, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and non monotonic dose responses. Endocr Rev 2012 ; 33 : 378–455. [CrossRef] [PubMed] [Google Scholar]
  15. Prins GS, Ye SH, Birch L, Ho SM, Kannan K. Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats. Reprod Toxicol 2011 ; 31 : 1–9. [CrossRef] [PubMed] [Google Scholar]
  16. Bouskine A, Nebout M, Brücker-Davis F, Benahmed M, Fenichel P. Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor. Environ Health Perspect 2009 ; 117 : 1053–1058. [CrossRef] [PubMed] [Google Scholar]
  17. Delfosse V, Grimaldi M, Pons JL, et al. Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes. Proc Natl Acad Sci USA 2012 ; 109 : 14930–14935. [CrossRef] [Google Scholar]
  18. Pupo M, Pisano A, Lappano R, et al. Bis-phenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts. Environ Health Perspect 2012 ; 120 : 1177–1182. [CrossRef] [PubMed] [Google Scholar]
  19. Rubin BS. Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 2011 ; 127 : 27–34. [CrossRef] [PubMed] [Google Scholar]
  20. Vandenberg LN, Chahoud I, Heindel JJ, et al. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 2010 ; 118 : 1055–1070. [CrossRef] [PubMed] [Google Scholar]
  21. Taylor JA, Vom Saal FS, Welshons WV, et al. Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ Health Perspect 2011 ; 119 : 422–430. [CrossRef] [PubMed] [Google Scholar]
  22. Chalbos D, Vignon F, Keydar I, Rochefort H. Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). J Clin Endocrin Metab 1982 ; 55 : 276–283. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.